November 7, 2018 / 7:51 AM / 15 days ago

BRIEF-Bone Therapeutics Announces Conclusions From Interim Analysis Of Phase III PREOB Study

Nov 7(Reuters) - BONE THERAPEUTICS SA:

* ANNOUNCED ON TUESDAY CONCLUSIONS FROM INTERIM ANALYSIS OF PHASE III PREOB STUDY IN HIP OSTEONECROSIS

* DSMB RECOMMENDED THE DISCONTINUATION OF THE TRIAL

* CO IS TAKING STEPS TO NOTIFY INVESTIGATORS THAT ENROLMENT OF PATIENTS IN THE TRIAL IS BEING STOPPED

* CO WILL FOCUS ITS CELL THERAPY DEVELOPMENT ACTIVITIES AND RESOURCES ON ITS OFF-THE-SHELF, ALLOGENEIC PLATFORM, ALLOB

Source text for Eikon:

Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below